醫療影像及報告實作指引 - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: DiagnosticReportLC - JSON Representation

Raw json | Download

{
  "resourceType" : "DiagnosticReport",
  "id" : "DiagnosticReportLC",
  "meta" : {
    "profile" : [
      🔗 "https://hapi.fhir.tw/fhir/StructureDefinition/DiagnosticReport-LC"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: DiagnosticReport DiagnosticReportLC</b></p><a name=\"DiagnosticReportLC\"> </a><a name=\"hcDiagnosticReportLC\"> </a><a name=\"hcDiagnosticReportLC-en-US\"> </a><h2><span title=\"Codes:{http://loinc.org 22637-3}\">Pathology report final diagnosis Narrative</span> (<span title=\"Codes:{http://loinc.org LP7839-6}\">Pathology</span>) </h2><table class=\"grid\"><tr><td>Subject</td><td>No display for Patient </td></tr><tr><td>Reported</td><td>2021-06-23 14:35:32+0000</td></tr><tr><td>Performer</td><td> <a href=\"Practitioner-TWCorePractitioner.html\">Practitioner 大吉 連 (official)</a></td></tr><tr><td>Identifier</td><td> <code>https://www.vghtpe.gov.tw/</code>/123456</td></tr></table><p><b>Report Details</b></p><table class=\"grid\"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Flags</b></td><td><b>When For</b></td></tr><tr><td><a href=\"Observation-GrossFinding.html\"><span title=\"Codes:{http://loinc.org 22634-0}\">Pathology report gross observation Narrative</span></a></td><td>The specimen received in formalin has 3 parts. Part (A) consists of a piece of lung, labeled RLL segment and measures 6.5 x 3.3 x1.8 cm. A gray white firm tumor, 1.2 x 0.5 x 0.5 cm, is noted 0.8 cm from the bronchial cut end, 0.1 cm from visceral pleura.Part (B) consists of groups of lymph nodes labeled as above.Part (C) is a piece of lung labeled 'RLL margin', measuring 3.8x 1.8 x 1 cm. Representative parts are taken for sections in 5 blocks. (A:bronchial and vascular cut end, B:stapled margin,C:tumor, D:specimen labeled 'RLL margin', E:interlobar LNs)(WKW)</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Histologictype.html\"><span title=\"Codes:{http://loinc.org 33731-1}\">Histology type in Cancer specimen Narrative</span></a></td><td><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-Morphology 81402}, {https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-Morphology 85503}\">adenocarcinoma,acinar predominant</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Histologicpattern.html\"><span title=\"Codes:{http://snomed.info/sct 255711007}\">Pattern (attribute)</span></a></td><td><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-Histologic-pattern acinar}, {https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-Histologic-pattern lepidic}\">acinar(90%),lepidic(10%)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Celltype.html\"><span title=\"Codes:{http://loinc.org 32760-1}\">Cell type in Specimen</span></a></td><td>non-mucinous tumor cells</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Resectionmargin.html\"><span title=\"Codes:{http://loinc.org 21939-4}\">Surgical margins cancer involvement</span></a></td><td>free of tumor involvement</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Nontumorousparenchyma.html\"><span title=\"Codes:{http://snomed.info/sct 113255004}\">Structure of parenchyma of lung (body structure)</span></a></td><td>congestion</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Totaltumorsize.html\"><span title=\"Codes:{http://loinc.org 21889-1}\">Size Tumor</span></a></td><td>0.6x0.4cm</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Sizeofinvasivefocus.html\"><span title=\"Codes:{http://loinc.org 33759-2}\">Deepest extent of invasion [Type] in Specimen</span></a></td><td>0.6 cm<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM  codecm = 'cm')</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Angiolymphaticinvasion.html\"><span title=\"Codes:{http://loinc.org 59544-7}\">Lymph-vascular invasion Cancer specimen</span></a></td><td><span title=\"Codes:{http://loinc.org LA9634-2}\">absent</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Perineuralinvasion.html\"><span title=\"Codes:{http://loinc.org 92837-4}\">Perineural invasion [Presence] in Cancer specimen</span></a></td><td><span title=\"Codes:{http://loinc.org LA9634-2}\">absent</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Pleuralinvasion.html\"><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-MicroscopicFinding Pleural-invasion}\">Pleural invasion</span></a></td><td><span title=\"Codes:{http://loinc.org LA9634-2}, {https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-Pleural-Invasion PL0}\">absent(PL0)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-SpreadThroughAirSpaces.html\"><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-MicroscopicFinding STAS}\">Spread Through Air Spaces(STAS)</span></a></td><td><span title=\"Codes:{http://loinc.org LA9634-2}\">absent</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Tumornecrosis.html\"><span title=\"Codes:{http://snomed.info/sct 34823008}\">Tumor necrosis (morphologic abnormality)</span></a></td><td><span title=\"Codes:{http://loinc.org LA9634-2}\">absent</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Tcategory.html\"><span title=\"Codes:{http://loinc.org 21899-0}\">Primary tumor.pathology Cancer</span></a></td><td><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-pT T1a}\">tumor &lt;=1 cm or less in greatest dimension(pT1a)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Lymphnodes.html\"><span title=\"Codes:{http://loinc.org 21900-6}\">Regional lymph nodes.pathology [Class] Cancer</span></a></td><td><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-pN N0}\">all without metastatic tumor(pN0)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Metastasis.html\"><span title=\"Codes:{http://loinc.org 21901-4}\">Distant metastases.pathology [Class] Cancer</span></a></td><td><span style=\"color: maroon\" title=\"Error\">Error: <b><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/data-absent-reason unknown}\">unknown</span></b></span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Pathologicalstaging.html\"><span title=\"Codes:{http://loinc.org 21914-7}\">Stage group.other Cancer</span></a></td><td><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-pTNM IA1}\">pT1aN0</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Tumorgrading.html\"><span title=\"Codes:{http://snomed.info/sct 397005006}\">World Health Organization tumor classification (observable entity)</span></a></td><td><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-Grading G2}\">Grade group 2 (microscopic measurement)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href=\"Observation-Ancillarystudies.html\"><span title=\"Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-MicroscopicFinding Ancillary}\">Ancillary studies</span></a></td><td>Tumor cell positive for TTF-1 and negative for p40;Multinucleate giant cell negative for CK</td><td>Final</td><td>2021-06-21</td></tr></table><p>Adenocarcinoma, acinar predominant, pT1aN0</p></div>"
  },
  "identifier" : [
    {
      "system" : "https://www.vghtpe.gov.tw/",
      "value" : "123456"
    }
  ],
  "status" : "final",
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://loinc.org",
          "code" : "LP7839-6",
          "display" : "Pathology"
        }
      ]
    }
  ],
  "code" : {
    "coding" : [
      {
        "system" : "http://loinc.org",
        "code" : "22637-3",
        "display" : "Pathology report final diagnosis Narrative"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/TWCorePatient"
  },
  "encounter" : {
    🔗 "reference" : "Encounter/TWCoreEncounter"
  },
  "issued" : "2021-06-23T14:35:32.631Z",
  "performer" : [
    {
      🔗 "reference" : "Practitioner/TWCorePractitioner"
    }
  ],
  "resultsInterpreter" : [
    {
      🔗 "reference" : "Practitioner/TWCorePractitioner"
    }
  ],
  "specimen" : [
    {
      🔗 "reference" : "Specimen/TWCoreSpecimen"
    }
  ],
  "result" : [
    {
      🔗 "reference" : "Observation/GrossFinding"
    },
    {
      🔗 "reference" : "Observation/Histologictype"
    },
    {
      🔗 "reference" : "Observation/Histologicpattern"
    },
    {
      🔗 "reference" : "Observation/Celltype"
    },
    {
      🔗 "reference" : "Observation/Resectionmargin"
    },
    {
      🔗 "reference" : "Observation/Nontumorousparenchyma"
    },
    {
      🔗 "reference" : "Observation/Totaltumorsize"
    },
    {
      🔗 "reference" : "Observation/Sizeofinvasivefocus"
    },
    {
      🔗 "reference" : "Observation/Angiolymphaticinvasion"
    },
    {
      🔗 "reference" : "Observation/Perineuralinvasion"
    },
    {
      🔗 "reference" : "Observation/Pleuralinvasion"
    },
    {
      🔗 "reference" : "Observation/SpreadThroughAirSpaces"
    },
    {
      🔗 "reference" : "Observation/Tumornecrosis"
    },
    {
      🔗 "reference" : "Observation/Tcategory"
    },
    {
      🔗 "reference" : "Observation/Lymphnodes"
    },
    {
      🔗 "reference" : "Observation/Metastasis"
    },
    {
      🔗 "reference" : "Observation/Pathologicalstaging"
    },
    {
      🔗 "reference" : "Observation/Tumorgrading"
    },
    {
      🔗 "reference" : "Observation/Ancillarystudies"
    }
  ],
  "imagingStudy" : [
    {
      🔗 "reference" : "ImagingStudy/ImagingStudyBase"
    }
  ],
  "conclusion" : "Adenocarcinoma, acinar predominant, pT1aN0"
}